Newel Health and Gerresheimer Unite for Integrated Digital Therapies

Newel Health and Gerresheimer have announced a strategic collaboration aimed at propelling pharmaceutical companies into the era of integrated digital therapies. This partnership merges Newel's H-Core platform and AI capabilities with Gerresheimer's expertise in drug delivery and pharmaceutical packaging. This union aims to support the development of digital medical devices and integrated drug-digital solutions.

Through this collaboration, the companies seek to facilitate real-world data generation and personalized medicine on a larger scale. They will work collaboratively with pharma and biotech firms to design digital endpoints and develop digital medical devices, promoting a seamless integration of real-world data and AI insights. This initiative underscores their commitment to optimizing patient care through advanced technological solutions.